chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT COMPLAINED OF MILD TINGLING AND ITCHING IN THE THROAT. THIS PERSISTED UNTIL APPROX. 12:00 PM WHEN THE PATIENT REPORTED REACTION TO PHARMACIST AND WAS TOLD TO TAKE ORAL DIPHENHYDRAMINE. SYMPTOMS RESOLVED WITH DIPHENHYDRAMINE.
pt recv vax 29MAY97 & devel recurrent n/v persisting for several days;pt was bedridden throughout this episode;pt was not hosp;pt was treated for the events w/IV fluids;
mom reported an episode of laying limp but responded to mom as picked up, lasting for few min??
Severe dizziness and nausea since Saturday 2/13/2021 . Called doctor who prescribed medication.  Nausea has abated, but dizziness is still an issue. This is the fourth day.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Mar2021 as dose 1, single (Lot number: EN6208), in left arm, on 19Apr2021 as dose 2, single (Lot number: EU0161), in left arm and on 16Nov2021 as dose 3 (booster), single (Lot number: EW047) at the age of 54 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: allergic to eggs" (unspecified if ongoing); "pagets disease of the bone" (unspecified if ongoing); "spinal stenosis" (unspecified if ongoing); "Arthritis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative, notes: Tested negative four days later; (25Apr2022) Positive, notes: Tested positive again on 25Apr2022; (27Apr2022) Negative, notes: Tested negative again on 27Apr2022; (29Apr2022) Negative, notes: again today on 29Apr2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient did not receive other medication in 2 weeks.The patient took Paxlovid for the treatment of COVID-19 from 10Apr2022 to 15Apr2022, started feeling better two days later. Tested negative four days later. Then, five days after testing negative, patient became ill again with a low fever and horrible sinus infection. Tested positive again on 25Apr2022. Tested negative again on 27Apr2022 and again on 29Apr2022. Feeling much better on the day of reporting.
Moderna Covid-19 Vaccine EUA           I had no symptoms for the first 24 hours.  The next morning, I awoke with severe vertigo.  The entire room was spinning and I could hardly walk due to poor balance.  Every time I moved my head, the vertigo would recur.  This caused nausea and vomiting so I spent much of the day in bed.  In the late afternoon, the vertigo lessened after I took an anti-emetic drug.  I only ate clear liquids the first day.  Since then, I have improved but still have mild morning vertigo.and mild fatigue.
This Non valid spontaneous report was received from a registered nurse and refers to an unspecified number of unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On dates on or after 21-SEP-2017, the patients were vaccinated with improperly stored dose of PEDVAXHIB for prophylaxis, lot# N000238 with expiration date of 25-OCT-2019, lot# N003701 with expiration date of 01-NOV-2019, lot# N008079 with expiration date of 02-DEC-2019, lot# N012920 with expiration date of 07-FEB-2020 (strength, dose, route and frequency were not reported); or with improperly stored dose of RECOMBIVAX HB for prophylaxis, lot# N020613 with expiration date of 05-MAY-2020, lot# N002202 with expiration date of 04-NOV-2019, lot# N011851 with expiration date of 19-DEC-2019; or with improperly stored dose of ROTATEQ orally, for prophylaxis, lot# N000175 with expiration date of 20-SEP-2018, lot# N005618 with expiration date of 04-OCT-2018, lot# N005078 with expiration date of 22-NOV-2018; or with improperly stored dose of VAQTA for prophylaxis, reported lot# M019924 with expiration date of 02-SEP-2018, lot# N008823 with expiration date of 26-MAY-2018. No adverse effects were reported. It was stated that the vaccines underwent a temperature excursion of 32°F (degrees Fahrenheit) to 35°F for 40 minutes; No previous temperature excursion was done. The call was because of a "data logger". This is a non-valid case due to lack of patient identifier. Follow up information was received from the registered nurse 30-APR-2018. The nurse stated the temperature excursion was stable and they had two refrigerators that held the related vaccines. The nurse was not able to provide patients' names or initials, or ages, but was able to provide number of patients, gender information, and vaccination dates. This report referred to three male patients vaccinated with improperly stored ROTATEQ (oral; lot# N005078 with expiration date 22-NOV-2018) on 22-SEP-2017. Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received. This is one of several reports received form the same reporter(link reports: 1710USA004069, 1805USA001661, 1805USA004617, 1805USA004618, 1805USA004590, 1805USA004591, 1805USA004592, 1805USA004593, 1805USA004674, 1805USA004675, 1805USA004677, 1805USA004678, 1805USA004679, 1805USA004680, 1805USA004681, 1805USA004682, 1805USA004683, 1805USA004967, 1805USA004968, 1805USA004969, 1805USA004970, 1805USA004971, 1805USA004972, 1805USA004973, 1805USA004974, 1805USA004975, 1805USA004976, 1805USA004977, 1805USA004978, 1805USA004979, 1805USA004980, 1805USA004981, 1805USA004982).
Initial report was received from a healthcare professional on 26 October 2012. A female patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of ADACEL vaccine (lot number: unknown by reporter, dose, dose number not reported) in Right Deltoid on 14 July 2012. The reporter stated that, on unspecified date the patient experienced pain in arm and decreased range of motion. The reporter states that, on an unspecified date a biopsy was done and culture was negative. Complementary diagnostic tests and laboratory data were not reported. The patient was not recovered at the time of report. Follow-up information was received on 26 October 2012 by a company representative from a health care professional who reported that an MRI revealed osteomyelitis. Based upon this new information, the case which also involved misuse (given ADACEL "incorrectly" in the arm) has been upgraded to serious. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
anaphylaxis to influenza vaccination less than two months ago; Initial information received on 28-Jan-2021 regarding an unsolicited valid serious courtesy case from a physician.  This case involves a patient of an unknown age and gender who experienced anaphylaxis (anaphylactic reaction), after receiving INFLUENZA VACCINE.  Past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious anaphylaxis (anaphylactic reaction) (unknown latency, medically significant) after vaccination with influenza, less than two months ago.  Also reported: physician allergist stated, that the question was regarding the PEG (Polyethylene glycol) that's in the Pfizer Covid (coronavirus disease) (PFIZERBIONTECH COVID-19 VACCINE) vaccine, question was whether there is a polysorbate in the vaccine that he received, which was the fluzone quadrivalent and wondering if that is going to cross react with the PEG in the Pfizer vaccine. The chemical name that was given in the descriptions of the fluzone quadrivalent was ethyleneoxide, and need to know from someone who is closer to chemistry than physician is, if that was  polysorbate. Caller is in the vaccination clinic and has a potential vaccine recipient (who is scheduled to receive the vaccine today) in which had anaphylaxis to influenza vaccination less than two months ago  Adverse Event involving Influenza vaccination The patient did not experience any additional symptoms/events. Medication Details and reason for taking the medicine: Prophylactic Vaccination . It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the event anaphylactic reaction.  Information on the batch number to be requested for this case.; Sender's Comments: This case involves patient who had anaphylactic reaction, after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. Moreover, patient's medical condition at the time of vaccination and lab tests were not reported. Based upon the reported information, the role of  vaccine cannot be assessed.
Extremely tired, and muscle pain in right shoulder + right arm. This is day 5 after vaccination, it started out mild tiredness now worse.
HPV9 vaccine administered instead of Hepatitis A vaccine. Vaccine error. No side effects noted to date.
I received pfizer boaster shot on 12/13/2021 at around 4pm. Underarm close to the injection site is swollen like tennis ball. It is extremely painful. Today is 3rd day after the boaster shot. Pain is so much that my entire left side upper body is hurting too much. My doctor said it is expected to have some swelling in the lymph nodes, which I understand. However they are swollen like tennis ball and pain isn't going away. After second dose it persisted for more than 2 weeks. In addition to this, I am dizzy ever since I received my boaster shot. Again doctor's office told me it is expected, however I am not convinced with the kind of dizziness/vertigo I am having.  I just want to bring it to authorities to see if this needs to be followed up.
pt recvd MMR vax in childhood & on 14JAN94 lab tests revealed pt had rubella immunity & lack of rubeola immunity; No further details were provided;
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to unspecified number of unspecified patients of unknown age and gender. The patients concurrent conditions, medical history and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # L008059, expiration date: 18-DEC-2016 (dose, route of administration and location were not reported). No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
felt dizzy; headache; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program -159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date Mar2021 (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "felt dizzy"; HEADACHE (non-serious), outcome "unknown", described as "headache". Clinical course: The patient got the vaccine 2 weeks ago but has not received any email confirmation about the appointment of her 2nd dose. She added that she felt dizzy and experienced a headache after the 1st dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient got Pfizer COVID vaccine 5/27/21 but pharmacy did not realize he has obtained Janssen COVID vaccine  already in March 8, 2021. Patient has no immediate side effects or symptoms. When speaking to patient, he wanted both vaccines as he saw that there are better protection.
Recieved vaccination on 8/13/08.  Presented on 8/18/08 with concern about palpable lymph node on left side of neck.  Sent to HEENT who felt it was related to the vacccine and treated with antibiotic and steriod.
Runny nose; severe headache; fever; chills; body aches and pains; felt totally exhausted; not feeling well.; This is a spontaneous report from a contactable consumer (patient's sister). A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EP6955 and expiry date not reported), via an unspecified route of administration, administered in Arm Right, on 24Mar2021 15:45 (at the age of 56-year-old), as dose 2, single, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had no allergies to medications, food, or other products. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EN6203 and expiry date not reported), via an unspecified route of administration, administered in Arm Left, on 03Mar2021 11:45 (at the age of 56-year-old), as dose 1, single, for COVID-19 immunisation and experienced headache in the right eye was most troublesome, nausea, diarrhea, achy, severe exhaustion. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 4:00am, the patient experienced severe headaches, fever, runny nose and chills, body aches and pains, felt totally exhausted for 2 days. Missed the next day of work due to not feeling well. The treatment received for the events was excedrin (over the counter). The outcome of the events was recovered.  No follow-up attempts are needed. No further information is expected.
PROLONGED AND HEAVY MENSTRUAL BLEEDING. PERIODS LASTING BETWEEN 10-20 DAYS WITH VERY HEAVY BLEEDING
This spontaneous report as received from a Licensed Practical Nurse (L.P.N.) refers to a currently 17 years old non-pregnant female patient. The patient had none pertinent medical history, none concomitant medications and none drug reactions or allergies. On 20-AUG-2012, the patient was vaccinated with the first dose of GARDASIL, 0.5 ml, intramuscularly (lot # H010649, expiration date 20-FEB-2015). On an unknown dates, after the administration of the first dose of GARDASIL, the patient experienced joint aches, backaches, dizziness, weakness, trouble walking, weak and tingly all over, felt limp, fatigued, "affected her ability to cope with things", "felt like everything in her body shut down", hips ache all the time and headaches. All of these events occurred intermittently except that her hips ache all the time. No treatment was given. On 23-AUG-2013, the patient was vaccinated with the second dose of GARDASIL, 0.5 ml, intramuscularly (lot # J006236, expiration date 25-FEB-2016). On 19-AUG-2014, the patient was vaccinated with the third dose of GARDASIL, 0.5 ml, intramuscularly (lot # K001631, expiration date 06-NOV-2016). The patient sought medical attention and she visited the office of physician on 28-APR-2015. It was unspecified which adverse events the patient sought medical attention for on that date. The outcome of the adverse events was not reported. The relatedness between the adverse events and GARDASIL was not reported. Additional information has been requested.
Pt woke up the next morning with a headache, chills, body-aches, fever, & sore arm. These symptoms lasted most of the day & then was okay in the evening.
Headache, nausea, fever of 100 degrees for a day, arm swelled up, sore for 3 days.  Missed work the following day due to illness.  Very red & hot at injection point.
sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Breast cancer.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported   No treatment medication reported Case is crosslinked to MOD21-068315 and MOD21-068279
Pt received GARDASIL vaccine and Hep A, MENACTRA, ADACEL. Pt waited in room with G-ma for a short time. They came out to front station when G-ma shouted she needed help. Pt. had fainted in front lobby. Staff called her name and she responded. Pt was lifted to a WC, and taken back to a room to lie down. Pt was oriented to place and time. Vitals taken and dr notified. Kept in room for 1/2 hour. Once pt. felt better, she was allowed to leave with G-ma.
3 days after received the Moderna vaccine I started to get sharp pains on the left side in my chest, it kept coming and going. I didn't think too much of it and thought it could be from gas possibly. As the days went on I kept feeling this pain and then it started to feel like I had gas trapped in the chest. By Monday, September 20, 2021 the chest pains would not go away and it started to worry me. My mid week of that week I called a Cardiologist to schedule and appointment and it was scheduled for two weeks out.  By Friday, September 24, 2021 I was still having the sharp chest pains that would not go away, I'm a healthy 34 year old and have no underlying health issues and a high immunity. After the sharp chest pains on the morning of Friday, September 24 around 9:00 am I started to have pain go towards my inner shoulder and then tingling and numbness down my left arm, my fingers began to go numb and tingling. I began to worry and thought I may be having a heart attack. I decided to go the  ER & Urgent Care to have it checked out by doing an Xray of my chest. The doctor saw to heart inflammation and didn't say what it could be, but ever since then I constantly have random chest pains with nerve pain going down my left arm. I've never had this in my life, until after I received the 1st dose of the Moderna vaccine - 3 days after the vaccine.  I am afraid to get my 2nd dose of the Moderna since my reaction can be even worse.
The same day as the vaccine, the arm where I got the vaccine was very sore, I also had significant muscle pain in my shoulders and was very tired. This passed within a few days. About 5 days after the vaccine my gums swelled up, and I got a cold sore on the corner of my mouth. I also had a raised bump on my tongue. The gums hurt for 4 or 5 days starting in a deep pocket around one of my teeth where I food gets caught so at first I thought it was a dental issue, then it spread to all of my gums. About 2 days after the gums swelled up the cold sore and bump on my tongue presented. About 7-8 days after the gums swelled up, all symptoms went away. The bump on the tong went away first, then the gum swelling, and more slowly, the cold sore. I didn't take anything throughout the period except routine vitamins and Ibuprofen. I did rinse my mouth with Peridex that I had on hand 2x per day for 3-4 days as this helped with the sore gums
15 to 20" p/vax dizziness, sweating;next day local rash;
Denied the second dose, did not receive second shot; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Denied the second dose, did not receive second shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Denied the second dose, did not receive second shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Denied the second dose, did not receive second shot) had resolved. Not Provided          NO CONCOMINANT DRUGS WERE MENTONED. TREATMENT DRUGS WERE NOT USED. LAB DATA WAS NOT GIVEN
I went from not needing insulin for 2 months to needing full doses of insulin before meals and also daily Lantis. Abdominal tenderness due to angry pancreas
fever; muscle/body aches; Muscle/body aches; This is a spontaneous report from a contactable consumer reporting for herself. A 57-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 25Feb2021 16:45 (Batch/Lot Number: EL9266) as single dose  for covid-19 immunisation (Age at vaccination 57 years).  Medical history included hypertension and allergy to codeine.  On 02Feb2021 the patient received the first dose of BNT162b2 for covid-19 immunisation  (lot number=EK9231).   Concomitant medications included lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; hctz (HCTZ) taken for an unspecified indication, start and stop date were not reported.   The patient experienced fever  on 26Feb2021 with outcome of recovering , muscle aches on 26Feb2021 with outcome of recovering , body aches  on 26Feb2021 with outcome of recovering.  The patient underwent lab tests and procedures which included body temperature: 100.1 Fahrenheit   for 36 hours.    No follow-up attempts are possible. No further information is expected.
Resident tested herself for antibodies and the test came back negative.; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EJ1686) via an unspecified route of administration on an unspecified date at single dose (dose number 1) and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EJ1686) via an unspecified route of administration on an unspecified date at single dose (dose number 2) for Covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller stated a resident at the hospital has had both doses of the pfizer covid 19 vaccine. Resident tested herself for antibodies and the test came back negative. Resident used the (name) home test kit. Caller wanted to know if the batch should be recalled. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
The day after the vaccine I developed a rash and severe itching and pain to the touch  this was on 2-16-2021.  The rash, itching and pain are still present on 2-24-2021.  The rash is about 2 -3 inches below injection site.  I have taken oral benadryl and topical cream with no real relief other than to help me sleep at night.  I also tried cool compresses which only exasperated the symptoms .  Called my doctor and had a telemed visit that only said to keep doing what I have been doing.  I was told to keep using cool compresses which I repeated over and over made symptoms worse.
Headache, Myalgia, Arthralgia, Fever, UrticariaPruritis & NauseaVomting Narrative:  Vaccinated @ 11am. At 10p, chills fever (102.4) with headache,  body muscle aches fatigue and nausea. Next day fever 102.6. Medicated with Tylenol 1000 mg x 2 with no effect. Took over the counter cold and flu with no effect by day 2. Fever 101.5 on day three. Day 4 afebrile with headache, body aches, fatigue. Day 5 fatigue only.